All Programs

Use the tool below to view all available Global Neurology Academy Series

Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
CME/CE Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
Learn more
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiers
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
- Aaron Miller, MD
Proactive Pregnancy Planning and Reproductive Care in MS
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiers
Proactive Pregnancy Planning and Reproductive Care in MS
- Riley Bove, MD, MMSc
Addressing Social and Systemic Barriers in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
- Shelina Ramnarine, PhD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Challenging the Status Quo in Schizophrenia Treatment
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of Schizophrenia
Challenging the Status Quo in Schizophrenia Treatment
- Shelina Ramnarine, PhD
- Stephen Marder, MD
The Social Brain in Schizophrenia
The Social Brain in Schizophrenia
On the Frontlines of Schizophrenia
The Social Brain in Schizophrenia
- Shelina Ramnarine, PhD
- Michael Green, PhD
Depression as a Signal of MS Progression
Depression as a Signal of MS Progression
NeuroFrontiers
Depression as a Signal of MS Progression
Target Locked in gMG: Why T2T Matters
Target Locked in gMG: Why T2T Matters
MinuteCE®
Target Locked in gMG: Why T2T Matters
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
FcRn: Same Class, Different Paths—Spot Agent Differentiators
FcRn: Same Class, Different Paths—Spot Agent Differentiators
MinuteCE®
FcRn: Same Class, Different Paths—Spot Agent Differentiators
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
1.00 credit 10 episodes
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
When to Begin FcRn: Initiation Criteria, Key Evidence
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®
When to Begin FcRn: Initiation Criteria, Key Evidence
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
The 2-Point Signal: Apply ≥2-Point Rule
The 2-Point Signal: Apply ≥2-Point Rule
MinuteCE®
The 2-Point Signal: Apply ≥2-Point Rule
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Family Planning in Patients with Multiple Sclerosis
Family Planning in Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning in Patients with Multiple Sclerosis
Strengthening Global Infrastructure for FSHD Trials
Strengthening Global Infrastructure for FSHD Trials
AudioAbstracts
Strengthening Global Infrastructure for FSHD Trials
- Marlene Mimi Maeusli, PhD.
Rethinking Progression in Multiple Sclerosis
Rethinking Progression in Multiple Sclerosis
NeuroFrontiers
Rethinking Progression in Multiple Sclerosis
- Charles Turck, PharmD, BCPS, BCCCP
- Christopher Lock, MD
Switching to Risdiplam Maintains Motor Gains in SMA Patients
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstracts
Switching to Risdiplam Maintains Motor Gains in SMA Patients
- Ryan Quigley

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD